Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis

Blood

Volumn 95, Issue 9, 2000, Pages 2780-2785

  Soria, José Manuel ^a   Almasy, Laura ^b   Souto, Juan Carlos ^b   Tirado, Isabel ^b   Borell, Montserrat ^b   Mateo, José ^b   Slifer, Susan ^b   Stone, William ^b   Blangero, John ^b   Fontcuberta, Jordi ^b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTHROMBIN;

ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; RISK ASSESSMENT; THROMBOGENESIS; THROMBOSIS;

EID: 0034193350     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.9.2780.009k36_2780_2785     Document Type: Article

References (42)

1. Rosendaal FR. Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin Hematol. 1997;34:171.
2. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3í-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase venous thrombosis. Blood. 1996; 88:3698.
3. Gonzalez-Conejero R, Lozano ML, Rivera J, et al. Polymorphisms of platelet membrane glycoprotein Ibβ associated with arterial thrombotic disease. Blood. 1998;92:2771.
4. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (APC resistance). Blood. 1995;85:150.
5. Spek CA, Koster T, Rosendaal FR, Bertina RM, Reitsma PH. Genotypic variation in the promoter region of the protein C gene is associated with plasma protein C levels and thrombotic risk. Arterioscler Thromb Vasc Biol. 1995;15:214.
6. Souto JC, Coll I, Llobet D. The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population. Thromb Haemost. 1998;80:366.
7. Brown K, Luddington R, Williamson D, Baker P, Baglin T. Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′-untranslated region of the prothrombin gene. Br J Haematol. 1997;98:907.
8. Arruda VR, Annichino-Bizzacchi JM, Gonçalves MS, Costa FF. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost. 1997;78: 1430.
9. De Stefano V, Chiusolo P, Paciaroni K, et al. Prevalence of the factor II G20210A mutation in symptomatic patients with inherited thrombophilia. Thromb Haemost. 1998;80:342.
10. Ferraresi P, Marchetti G, Legnani C, et al. The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arterioscler Thromb Vasc Biol. 1997;17:2418-2422.
11. Hillarp A, Zöller B, Svensson PJ, Dahlbäck B. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost. 1997;78:990.
12. Souto JC, Mateo J, Soria JM, Coll I, Llobet D, Fontcuberta J. Homozygotes for prothrombin gene 20210 A allele in thrombophilic family without clinical manifestations of venous thromboembolism. Haematologica. 1999;84:627.
13. Souto JC, Almasy L, Borrell M, et al. Genetic determinants of hemostasia phenotypes in Spanish families. Circulation. In press.
14. Zivelin A, Rosenberg N, Faier S, et al. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood. 1998;92:1119.
15. Ruiz A, Barbadilla A. The contribution of quantitative trait loci and neutral marker loci to the genetic variances and covariances among quantitative traits in randomly mating populations. Genetics. 1995;139:445.
16. Almasy L, Williams JT. Dyer TD, Blangero J. QTL detection using combined linkage/disequilibrium analysis. Genet Epidemiol. 1999;17(suppl 1):531.
17. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64.
18. Espinosa Y, Morell M, Souto JC, et al. Absence of linkage between type III protein S deficiency and the PROS1 and C4BP genes in families carrying the protein S Heerlen Allele. Blood. 1997;89:2799.
19. Hasstedt S, Bovill EG, Callas PW, Long GL. An unknown genetic defect increases venous thrombosis risk, through interaction with protein C deficiency. Am J Hum Genet. 1998;63:569.
20. Hennis BC, Van Boheemen PA, Koeleman BP, et al. A specific allele of the histidine-rich glycoprotein (HRG) locus is linked with elevated plasma levels of HRG in a Dutch family with thrombosis. Br J Haematol. 1995;89:845.
21. Rosendaal FR, Doggen CJM, Zivelin A. et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost. 1998;79:706.
22. Cumming AM, Keeney S, Bhavnani M, Shwe KH, Hay CRM. The prothrombin gene variant: prevalence in U.K. anticoagulant clinic population. Br J Haematol. 1997;98:353.
23. Howard TE, Marusa M, Boisza J, et al. The prothrombin gene 3′-untranslated region mutation is frequently associated with factor V Leiden in thrombophilic patients and shows ethnic-specific variation in allele frequency [letter]. Blood. 1998; 91:1092.
24. De Maat MPM, Bladbjerg EM, Johansen LG, Gram J, Jespersen J. Absence of prothrombin mutation in Inuit (Greenland Eskimos). Thromb Haemost. 1998;79:882.
25. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 1998; 6:1215.
26. Ripoll L, Paulin D, Thomas S, Drouet LO. Multiplex PCR-mediated site-directed mutagenesis for one-step determination of factor V Leiden and G20210A transition of the prothrombin gene. Thromb Haemost. 1997;78:960.
27. Dyke B. PEDSYS: a pedigree data management system [user's manual]. San Antonio, TX: Southwest Foundation for Biomedical Research; 1995. Population Laboratory, Department of Genetics, PGL Tech Rep, No. 2.
28. Almasy L, Blangero JC. Multipoint quantitative trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62:1198.
29. Duggirala R, Williams JT, Williams-Blangero S, Blangero J. A variance component approach to dichotomous trait linkage analysis using a threshold model. Genet Epidemiol. 1997;14:987.
30. Williams JT VanEerdewegh P, Almasy L, Blangero J. Joint multipoint linkage analysis of multivariate qualitative and quantitative traits: I. Likelihood formulation and simulation results. Am J Hum Genet. 1999;65:1134.
31. Hopper JL, Matthews JD. Extensions to multivariate normal models for pedigree analysis. Ann Hum Genet. 1982;4:373.
32. Amos CI. Robust variance-components approach for assessing genetic linkage in pedigrees. Am J Hum Genet. 1994;54:535.
33. Kendall MG, Stuart A. The Advanced Theory of Statistics. Volume 2. Inference and Relationship. New York, NY: Hafner; 1967.
34. Self SG, Liang K-Y. Asymptotic properties of maximum likelihood estimators and likelihood ratio tests under nonstandard conditions. J Am Stat Assc. 1987;82:605.
35. Boehnke M, Lange K. Ascertainment and goodness of fit of variance component models for pedigree data. Prog Clin Biol Res. 1984;147:173.
36. Zabalegui N, Montes R, Orbe J, et al. Prevalence of FVR506Q and prothrombin 20210A mutations in the Navarrese population. Thromb Haemost. 1998;80:522.
37. Iacoviello L, Di Castelnuovo A, de Knijff P, et al. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med. 1998;338:79.
38. Weiss KM. Genetic Variation and Human Disease. Cambridge: Cambridge University Press; 1993.
39. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337:230.
40. Den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996;334:759.
41. Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet. 1995;345:152.
42. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease. The atherosclerosis risk in communities (ARIC) study. Circulation. 1997;96:1102.